UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
Formula based on milk and whey protein
Severe chronic constipation can lead to problematic complications like fecal impaction and fissures (Basilisco 2013
Select any of the image buttons to change the main image
Support Natural GLP-1 Production This premium drink mix is designed with Yerba Mate and Garcinia Cambogia to naturally stimulate GLP-1 levels, helping to promote appetite modulation and metabolic balance for women and men
Deficiencies can occur with medical conditions such as atrophic gastritis (which causes thinning of the stomach lining), pernicious anaemia, Crohns disease, celiac disease, lupus, or other immune system disorders and certain medications